One hundred ten genes for human glycosyltransferases had been cloned and analyzed at the beginning of April, 2001 after the first mammalian glycosyltransferase gene was cloned in 1986. The term glycogene includes the genes for glycosyltransferases, sulfotransferases adding sulfate to carbohydrates and sugarnucleotide transporters, etc. In April 2001, we started the Glycogene Project (GG project), which was a comprehensive study on human glycogenes. One hundred five novel glycogenes were identified as candidates with the aid of bioinformatic technology. All of them were cloned and expressed as recombinant enzymes, and their substrate specificities were then examined using various acceptors. Thirty-eight glycogens among the 105 candidates were determined to be glycosyltransferases, sulfotransferases and sugar-nucleotide transporters. One hundred sixty-five glycogenes were subcloned into a Gateway entry vector, and prepared as a human glycogene library. These cloned glycogens can be easily expressed as recombinant enzymes in various expression systems.
A new term glycogene was given to the genes involved in glycosylation of proteins, lipids and proteoglycans. Glycogenes include the genes for 1) glycosyltransferases, 2) glycolytic enzymes, 3) sugar nucleotide synthetases, 4) sugar nucleotide transporters, and, in a broader sense, sugar chain recognizing molecules such as 5) lectins.
Human genome analysis has almost been completed, and the number of the genes was estimated to be about 30,000; that is quite a bit smaller than the predicted number. We propose that posttranslational modifications such as phosphorylation and glycosylation are important to increase the protein function. Suppose that different structures of glycosylation are on a single protein; glycosylation may confer different functions to the protein. Thus, the consideration of protein functions should include posttranslational modifications.
One gene is involved in the synthesis of the protein moiety of a glycoprotein, whereas dozens of genes are involved in the synthesis of its sugar chain moiety. Thus, a single glycoprotein is the joint product of dozens of genes. We speculate that human beings could evolve from lower eukaryotes with a small increase in the number of genes; however, each protein function of higher eukaryotes might be more intricately regulated by glycosylation than that of lower eukaryotes.
To understand the complex structures and functions of glycosylation, we need to obtain all glycogenes on hand, because one structure of glycosylation is formed by cooperative and stepwise reaction of many glycogenes. Therefore, we started the comprehensive identification and functional analysis of human glycogens. These are ex-pected to dramatically advance: 1) the elucidation of the functions of sugar chains as bioactive substances including carrier molecules, 2) the elucidation of control mechanisms of carrier molecules by sugar chains, 3) the development of analytical techniques for sugar chain structures, and 4) the development of automated synthesis techniques for sugar chains.
The project Construction of a Human Glycogene Library and Comprehensive Functional Analysis (the GG project) was supported by the New Energy and Industrial Technology Development Organization (NEDO) of the Ministry of Economy, Trade and Industry (METI) of Japan, and performed by us from April, 2001, to March, 2004.
Bioinformatics was powerful to identify novel glycogenes in the databases.
We constructed a system for predicting novel glycosyltransferase genes from the primary sequence characteristics shared by glycosyltransferases. This system has functions such as an automated BLAST search, automatic removal of known sequences, assembly of EST search results (EST sequence hits are assembled with Phrap to eliminate duplicate hits for better search efficiency), and prediction of gene regions in genome sequence search results (in the genome sequence search, gene regions are predicted with GENSCAN, and the amino acid sequence for the entire ORF is obtained), in combination with the program described below to identify glycosyltransferases. The general characteristics of glycosyltransferases are as follows: 1) The N terminus is short and within the cytoplasm; 2) The trans Golgi membrane region (a sequence of approximately 18 20 residues rich in hydrophobic amino acids) is in the vicinity of the amino terminus; 3) This region is followed by the stem domain, which is J. Appl. Glycosci., 52, 197 201 (2005) ! C 2005 The Japanese Society of Applied Glycoscience rich in proline (an amino acid forming a non high order structure) and in the O glycan linked amino acid residues serine and threonine; 4) The C terminus is followed by an approximately 300 400 residue catalytic site; 5) The catalytic site contains D D or D H, an amino acid sequence necessary for binding divalent cations. 1 4) In addition to these characteristics, several motif regions were set up for every existing gene family using MEME, 5) then a program was designed to assess six items including whether the motif regions are present, and has been used to determine possible glycosyltransferases. However, since this system is only capable of detecting genes with some degree of homology to the existing ones, we are in the process of expanding its functions, such as the incorporation of software capable of comparing high order structures. These systems are sufficiently applicable to the analysis of not only glycosyltransferase genes but also various other genes including lectin genes.
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Current status of glycogene research.
Since the first mammalian glycosyltransferase gene was cloned by two groups independently, 6, 7) more than 160 human glycosyltransferase genes have been cloned to date. Figure 1 summarizes the number of human glycogenes which were reported to date. In total, 166 glycogenes were reported, mostly by Japanese researchers. 8) The numbers in parentheses indicate the glycogenes which were analyzed and reported in the GG project. Sixty eight candidate genes still remain to be analyzed for their activity. Nineteen genes were found to be pseudogenes. Thirty eight glycogenes in total were reported by the GG project. The details of each gene will be referenced in the original papers published by us. 9 35) The sequence of studies is as follows: 1) Glycogenes are cloned, and the encoded enzymes are expressed by various methods; 2) The enzymes are analyzed for the synthesis of sugar chain structures in vitro or in vivo. Subsequently, the synthesized sugar chain structures are examined for their biological functions as follows: 3) Glycogenes are transfected into cultured cells, and the functions of the cells whose sugar chain structures have undergone changes are analyzed.
The characteristics of a few glycosyltransferase gene families and their substrate specificities are presented below along with the results of the GG project. For more details, the reader is referred to our cited publications.
Glycosyltransferase gene family with β 4-glycosyltransferase (β 4GT) motif.
The 4 galactosyltransferase ( 4Gal T) gene was the first glycosyltransferase cloned. 6, 7) 4Gal T forms a family including seven enzymes, 4Gal T1 through 4Gal T7, which share the same characteristic of transferring galactose from the sugar donor UDP Gal to the sugar acceptor via a 1,4 linkage, but differ in using sugar acceptors such as sugar chains in glycoproteins, glycolipids, or glycosaminoglycans. Using the amino acid sequences of this family as query sequences, we performed database searches and found eight new members sharing a 4GT motif, GWGXED. Six of them were finally determined to be the genes involved in the synthesis of chondroitin sulfate. 9 13) Chondroitin sulfate occurs as a sugar chain of proteoglycans in which dozens of the disaccharide repeating unit ( GlcA 1,3GalNAc 1,4 ) are bound to a serine residue of the core protein via a linkage tetrasaccharide (GlcA 1,3Gal 1,3Gal 1,4Xyl ). In addition, two novel members were found recently and their substrate specificity was analyzed. 14, 15) They were identified as the enzymes responsible for the synthesis of the N,N diacetyllactosediamine (LacdiNAc), GalNAc 1 4GlcNAc, structure. The LacdiNAc structure on N glycans were found on some specific glycoproteins which are glycoprotein hormones. The LacdiNAc structure was reported to determine the half life time of these hormones in blood.
All members in the 4GT family, the 4 galactosyltransferase gene, the chondroitin sulfate synthesizing enzyme gene and the LacdiNAc synthase families, have the amino acid sequence GWGXED in common, but differ in their sugar donors and acceptors, suggesting that this motif is the sequence specifying the 1,4 linkage.
Glycosyltransferase gene family with β 3-glycosyltransferase (β 3GT) motif.
The glycosyltransferase gene family with the 3 motif includes five 3 galactosyltransferases ( 3Gal T), six 3 N acetylglucosaminyltransferases ( 3Gn T) and two 3 N acetylgalactosaminyltransferases ( 3GalNAc T). Of the many 3Gn Ts reported by us, 3Gn T2 clearly shows the strongest activity for the sugar acceptor polylactosamine structures, suggesting that this is a polylactosamine synthesizing enzyme on glycoproteins. 18) We performed an in silico analysis using the database, successfully cloned the Lc3Cer synthesizing enzyme gene, 3Gn T5, 19) and the O liked sugar chain core 3 synthesizing enzyme gene, 3Gn T6, 20) and reported their substrate specificities. 3Gn T6 is restrictively localized in the epithelia of the stomach and colon, in which the major form of O glycans is the core 3 structure. This enzyme may be profoundly involved in cancer metastasis. A novel enzyme, named 3GalNAc T2, was found by in silico cloning and characterized. 21) 3GalNAc T2 transfers GalNAc to GlcNAc with a 3 linkage on the termini of N and O glycans. 21) Although the GalNAc 1 3 GlcNAc 1 R structure has not been reported in humans or other mammals, it must exist where the enzyme is expressed. Very recently, 3Gn T8 was identified as being responsible for the synthesis of polylactosamine chains on 1 6 branched N glycans, and dramatically up regulated in cancer tissue. 22) Polypeptide N-acetylgalactosaminyltransferase gene family. Polypeptide N acetylgalactosaminyltransferase ( pp GalNAc T) is a group of glycosyltransferases transferring GalNAc to serine or threonine residues in O glycans through an linkage. At the present time, 15 members of this family have been published. We cloned five of these genes, pp GalNAc T10, T12, T13, T14 and T15, and analyzed their functions. 23 28) The sequences of this enzyme family are characterized by the presence of conserved motifs called the GT1 and Gal GalNAc T motifs, and have homology throughout the entire lengths. Thus, it is easy to find homologous members in the databases. Besides the 15 members published, an additional five members can be found in the databases. However, the activity of these five candidates has not been detected yet.
Each pp GalNAc T exhibits different substrate specificity for the peptide sequence, and shows different tissue distribution. Thus, initiation of O glycosylation which is determined by the activity of pp GalNAc T is quite complicated in vivo. An example of such analyses is the case of multiple O linked sugar chains in the hinge region of IgA 1. Based on the tissue distribution of expression of the pp GalNAc T family and the differences in their relative activity determined with the hinge region peptide, we reported that pp GalNAc T2 transfers N acetylgalactosamine to the IgA 1 hinge region. 28) 
Conclusion.
At present, sugar chain engineering has been given the status of one of the key techniques of biotechnology in Japan. In fact, Japan is most advanced in the glycogene discovery for these years as shown in Fig. 2 . At the beginning of the GG project, Japan accounted for 50% of the glycogenes. The percentage increased to 61% for these three years because of the success of the GG project.
The GG project was performed as part of the R & D Project of Industrial Science and Technology Frontier Program (R & D for Establishment and Utilization of a Technical Infrastructure for Japanese Industry) supported by the New Energy and Industrial Technology Development Organization (NEDO).
